Analysis of the clinical features, treatment strategies, and results of Borderline ovarian cancers

Aim: The objective of our study was to evaluate the preoperative circumstances, treatments, and postoperative states of patients at our university hospital. Materials and Methods: This retrospective study used the Mersin University Hospital's gynecological oncology clinic database. Patient age, menopausal status, preoperative tumor markers, and preoperative ultrasonography features were collected from the hospital databases. After the initial procedure, information regarding the surgical method, histological classification, stage at the time of diagnosis, size of the tumor, status of the lymph nodes, and the ultimate pathological diagnosis were collected. Results: This study has a cohort of 84 patients who underwent surgery between 2007 and 2023. The study groups had a median age of 41.5, ranging from 15 to 88. Out of the total patients, 71.4% were in the premenopausal stage. Final pathology revealed the presence of a malignant tumor in 10 patients, accounting for 11.9% of the total. Out of the total number of patients, six had serous tumors, while four had mucinous tumors. Out of the 83 people, a recurrence of the condition was found in 3, indicating a rate of 3.6%. The mean duration of progression-free survival for these individuals was 19 months. Only individuals in the early stage of the disease experienced a recurrence, and two exhibited micropapillary variants. Conclusion: Ultimately, BOTs have a highly favorable prognosis. Patients who meet the criteria might consider undergoing fertility-preserving surgical procedures.